Viking Therapeutics, Inc. (VKTX)
33.23
-0.66
(-1.95%)
USD |
NASDAQ |
Aug 24, 16:00
33.55
+0.32
(+0.96%)
After-Hours: 05:55
Viking Therapeutics Shareholders Equity (Quarterly) : 408.32M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 408.32M |
| March 31, 2026 | 501.92M |
| December 31, 2025 | 639.06M |
| September 30, 2025 | 713.03M |
| June 30, 2025 | 795.46M |
| March 31, 2025 | 846.92M |
| December 31, 2024 | 880.28M |
| September 30, 2024 | 911.45M |
| June 30, 2024 | 920.98M |
| March 31, 2024 | 933.89M |
| December 31, 2023 | 348.42M |
| September 30, 2023 | 368.24M |
| June 30, 2023 | 386.12M |
| March 31, 2023 | 134.06M |
| December 31, 2022 | 145.32M |
| September 30, 2022 | 151.28M |
| June 30, 2022 | 165.23M |
| March 31, 2022 | 182.27M |
| December 31, 2021 | 201.88M |
| September 30, 2021 | 213.12M |
| June 30, 2021 | 224.97M |
| March 31, 2021 | 237.22M |
| December 31, 2020 | 244.34M |
| September 30, 2020 | 253.79M |
| June 30, 2020 | 261.95M |
| Date | Value |
|---|---|
| March 31, 2020 | 268.28M |
| December 31, 2019 | 277.12M |
| September 30, 2019 | 283.49M |
| June 30, 2019 | 288.35M |
| March 31, 2019 | 294.57M |
| December 31, 2018 | 297.75M |
| September 30, 2018 | 302.05M |
| June 30, 2018 | 140.36M |
| March 31, 2018 | 72.63M |
| December 31, 2017 | 13.46M |
| September 30, 2017 | 2.226M |
| June 30, 2017 | 6.588M |
| March 31, 2017 | 7.546M |
| December 31, 2016 | 8.043M |
| September 30, 2016 | 10.22M |
| June 30, 2016 | 12.79M |
| March 31, 2016 | 5.770M |
| December 31, 2015 | 8.725M |
| September 30, 2015 | 13.27M |
| June 30, 2015 | 17.39M |
| March 31, 2015 | -27.84M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | -23.26M |
| March 31, 2014 | -0.3979M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 20.25B |
| Eli Lilly & Co. | 33.88B |
| Regeneron Pharmaceuticals, Inc. | 31.71B |
| Skye Bioscience, Inc. | -0.4973M |
| Eledon Pharmaceuticals, Inc. | 72.03M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 521.90M |
| Total Liabilities (Quarterly) | 113.58M |
| Debt to Equity Ratio | 0.01 |
| Current Ratio | 4.720 |
| Net Debt Paydown Yield | -0.01% |